Tuesday, April 25, 2017

Novartis Profit Dented by Investment in New Drugs

Novartis said profit fell in the first quarter as it pumped investment into the launch of its new heart-failure drug Entresto that it hopes will help offset revenue lost as best-selling cancer medicine Gleevec loses out to cheaper competitors.

from WSJ.com: US Business http://ift.tt/2oFYK5l
via IFTTT

No comments:

Post a Comment